Towards Healthcare
Generative AI In Life Sciences Market Rises at 20.82% CAGR by 2034

Generative AI In Life Sciences Market Next Frontier in Drug Discovery and Precision Medicine

Market insights predict the global generative AI in life sciences industry will increase from USD 250 million in 2024 to USD 1,657.02 million by 2034, achieving a CAGR of 20.82%. Around the world, the generative AI in life sciences market is driven by its rapid adoption in different sectors, such as drug discovery, clinical trials, and other significant areas in life sciences. Whereas, North America led the market in 2024, due to beneficial investments by private and public sectors in AI and R&D, and favourable regulatory environments that accelerate innovations.

Content

  • Insight Code: 5735
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The generative AI in life science market is projected to reach USD 1,657.02 million by 2034, growing at a CAGR of 20.82% from 2024 to 2034.

North America is currently leading the generative AI in life science market due to substantial public and private investment in AI R&D, along with an advantageous regulatory environment that accelerates innovation.

The generative AI in life science market includes 3 segments, such as by technology, by application, and by region etc.

Some key players include IBM Corporation, AiCure LLC, MosaicML, and NVIDIA.

Key trends include rising demand for drug discovery and personalized medicine, growth in analysis of datasets, and innovation in clinical trials, novel molecules.

The main goal of generative AI is to generate novel and original content, such as text, images, audio, or code, based on patterns received from existing data.

The different generative AI techniques are deep learning, neural networks, and machine learning techniques.

US GAO.GOV, NIH.GOV, INDIAAI.GOV, IBM, PIB, CDC.GOV, GOV.UK
Any Questions